NCT00656812 2013-12-24Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) LymphomaArbeitsgemeinschaft medikamentoese TumortherapiePhase 2 Completed40 enrolled